Trends of Radiopharmaceutical Use at Mayo Clinic Rochester

Trends of radiopharmaceutical use at Mayo Clinic Rochester.

UNLABELLED The field of radiology is continuously changing. The purpose of this study was to identify the effect of technologic advances on nuclear medicine during the past 15 y. METHODS The number of radiopharmaceutical doses dispensed at Mayo Clinic (Rochester, Minnesota) from 1990 through 2004 was tracked. The number of doses was equivalent to the number of scans performed. RESULTS Since...

Rothia bacteremia: a 10-year experience at Mayo Clinic, Rochester, Minnesota.

Rothia spp. are Gram-positive cocco-bacilli that cause a wide range of serious infections, especially in immunocompromised hosts. Risk factors for Rothia mucilaginosa (previously known as Stomatococcus mucilaginosus) bacteremia include prolonged and profound neutropenia, malignancy, and an indwelling vascular foreign body. Here, we describe 67 adults at the Mayo Clinic in Rochester, MN, from 20...

Disseminated Mycobacterium genavense in the immunocompromised: A Case Series at Mayo Clinic Rochester

Intracranial meningiomas: experiences at the Mayo Clinic.

18 to 20, 1978. On June 1, 1885, Francesco Durante, professor of clinical surgery at the University of Rome, performed the first successful operation for an intracranial tumor when he removed a pre dominantly unilateral meningioma of the left olfactory groove. This procedure followed the celebrated Bennett-Godlee case, which resulted in a fatality, by only 6 months.' If we were to designate an ...

The first anesthetizers at the Mayo Clinic.